Publications by authors named "L Verlingue"

Claim this Profile
E
ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP).
E Y T Wong, L Verlingue, M Aldea, M A Franzoi, R Umeton

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation.
Capucine Baldini, Loic Verlingue, Vincent Goldschmidt, Bernard Doger de Spéville, Julia Lostes

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium.
S F Haj Mohammad, H van der Pol, E Vrdoljak, U Lassen, K Ojamaa, L Verlingue

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement.
I Korakis, K Ouali, B Hanvic, L Verlingue, B Allignet

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective pragmatic evaluation of automatic trial matching tools in a molecular tumor board.
Lilia Gueguen, Louise Olgiati, Clément Brutti-Mairesse, Alric Sans, Vincent Le Texier, Loic Verlingue

NPJ Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis